HELIX RESEARCH ACCESS PROGRAM

Advance your research with one of the world's largest clinicogenomic datasets

Introducing the new Helix Research Access Program which enables academic, government and non-profit researchers to apply for secure access to de-identified population-scale genomic data linked with longitudinal clinical records in a centralized genomic analysis platform to drive genetics research forward.

550K+ Exome-sequenced participants

13+ Yrs Longitudinal linked clinical records

OMOP Standard data model for interoperability

Secure De-identified access-controlled environment

WHAT YOU CAN DO

How researchers can use Helix data to drive research and insights

🧬

Genomic data paired with real clinical outcomes

Genomic data from Exome+® Sequencing is linked to clinical data (diagnoses, labs, medications, procedures) in an OMOP-standard model, so you can move beyond association and study how variants impact clinical outcomes.

💻

Run your own analysis in a secure environment

Helix Research Workspaces is a purpose-built Trusted Research Environment for population-scale genomic analysis, with an AI coding assistant designed to get researchers from question to answer faster without requiring access to specialized bioinformatics resources.

🚀

Accelerate discovery and publications

Replicate findings, power new population scale research, and strengthen grant applications using a dataset at a scale most single institutions cannot assemble on their own.

HOW TO GET ACCESS

From interest to access

Register your interest

Tell us who you are and the research area you want to explore. It takes less than a minute and allows us to reach out to you with more details.

Submit a research proposal

For interested researchers, Helix will provide a research proposal form to complete.

Get access and start working

Approved projects are provisioned into a dedicated workspace, where your team queries and analyzes data within the research environment.

ELIGIBILITY

Who can apply

The program is open to researchers at non-commercial research institutions, including academic, government, and nonprofit research organizations. The principal investigator and research collaborators must be located in the United States or Canada.

Access to the platform and data starts in early 2027.